Eretz.Bio is an initiative of the Sociedade Beneficente Israelita Brasileira Albert Einstein (Israeli Beneficent Society Albert Einstein) that works as an incubator of startups focused on innovation in
the health sector.
Month: November 2019
WeWork rescue skews October figures
Monthly Analysis: October 2019
Brazil goes for corporate venture
GCV was delighted to head to São Paulo in October to co-host the fifth annual Corporate Venture in Brasil conference, in partnership with ApexBrasil, and to hold our inaugural GCV Academy in the region.
Delegation rises to Japan’s opportunities
This year’s Global Corporate Venturing Asia Congress from October 1-2 welcomed a delegation of about 50 international corporate venturers.
The corporate capital correlation in 2019
Third-year update on CVC programs’ potential impact on public stock price performance
Balancing strategic and financial value
Balancing strategic and financial value [has been] a long-standing tension in the corporate venture capital (CVC) industry. Industry practitioners adopted various models over time, but academic researchers lent their insights to the debate as well.
Profiles of two CVCs a decade after formation
Across the industry, real-life CVCs developed a variety of approaches to balance the pursuit of strategic and financial value. The examples below provide a sense of the fairly wide spectrum that existed in 2019
The true value of technology
Michiel van Haersma Buma reflects on the collaboration between Shell Ventures and Halfwave
The future of mining
It is an irony that as the world moves to cleaner sources of energy it is increasingly reliant on one of the most challenging industries for the commodities.
Finding new ways to innovate through Rising Stars
Citi’s Vanessa Colella on ‘better together’
The importance of Rising Stars
2017 winner Rashmi Gopinath on her career since the award
LifeTech promises impact on life insurance
In a whitepaper titled “Emerging LifeTech ecosystem promises profound impacts on life insurance”, New York Life Ventures explores the implications of this new ecosystem on the future of the life insurance industry – and highlights how the team has invested accordingly.
Cracking the quantum puzzle
Academic research towards quantum computing and other quantum technologies is beginning to pay dividends, but continued progress will rely on strong cooperation between academic, industry and government partners.
The future is this way
Assessing the potential for Experian’s investments in early-stage innovators